If the stock market does one thing, it changes. And any system worth its computing power knows this and regularly tracks companies that are improving their performance. Our Zen Ratings system does just this, tracking 115 factors and assigning ratings and component grades to each stock we cover, with the top 5% of stocks receiving an A Zen Rating.
Stocks with an A Zen Rating have an average annualized return of +32.52%. And that deserves some attention.
There are plenty of stocks that rise to the top each week, but here we want to point out two in particular:
The age of everyone being on Zoom meetings and calls is several years over now, but that doesn’t mean Zoom meetings are gone. People still use it every day for webinars, meetings, working from home, and more.
And Zoom has handled the transition out of the absolute spotlight well, considering its Financials rating of A, which indicates that ZM has strong financial foundations and can safely manage its debts and liabilities. Its earnings estimates have also trended upward recently, rising from $1.35 EPS a year ago to $1.43 last quarter.
The pharmaceutical giant has been the subject of considerable discussion recently, with some calling it an underdog to watch, while others warn of overhype. For our two cents, our Zen Ratings system gives it an A rating. This is largely due to the recent correction it received from the market, with about a 20% downturn over the last six months.
This has brought it back into the realm of good value for many investors, and value investors will want to take a closer look at BMY. And this is all despite fears of President Trump announcing he plans to reduce U.S. drug prices. Interestingly, investors don’t seem to be reacting with panic to the news.
The other potential half of the equation for BMY is the annual dividend yield of 5.32%. Just note that this shouldn’t be the only factor for you. If you want to learn more about this subject, we have an excellent piece on dividend stocks here, written by Steve Reitmeister.
Want to easily find other top-rated stocks, both new and old? You’ve come to the right place. With WallStreetZen Premium, you’ll also receive access to an ideas page that tells you about upgrades and downgrades of key stocks. You’ll also receive an unlimited watchlist and all the fundamental information you need to make the best decisions for your portfolio.
And you can keep track of interesting stocks yourself, but that’s not always practical when there are thousands of them. If you’re worried about this, Zen Investor is what you need. With it, you’ll get selections and recommendations from our own Steve Reitmeister, who has more than 40 years of experience investing in and watching the market. You’ll also have access to regular updates and commentary that will provide context for why stocks are selected.
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.